UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000025664
Receipt number R000029523
Scientific Title Study on the mechanism of therapeutic effect on tinnitus using fMRI
Date of disclosure of the study information 2017/01/13
Last modified on 2017/01/13 16:47:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study on the mechanism of therapeutic effect on tinnitus using fMRI

Acronym

Study on tinnitus treatment effect by fMRI

Scientific Title

Study on the mechanism of therapeutic effect on tinnitus using fMRI

Scientific Title:Acronym

Study on tinnitus treatment effect by fMRI

Region

Japan


Condition

Condition

tinnitus

Classification by specialty

Oto-rhino-laryngology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We analyze therapeutic effect of tinnitus using functional MRI.

Basic objectives2

Others

Basic objectives -Others

we explore the mechanism and compare fMRI data between the patients with and witout tinnitus

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

we find out how the patinets with tinnitus improve.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Factorial

Randomization

Non-randomized

Randomization unit


Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification

YES

Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

We asked patinets to wear hering aid for tinnitus patients and patients without tinnitus (both have hearing loss).

Interventions/Control_2

We examine hearing tests, tinnitus tests
and fMRI analysis before and after hearing aid treatment for tinnitus patients and patients without tinnitus (both have
hearing loss) and the treatment mechanism of sound therapy wearing hearing aids.
Functional MRI photographs at the University of Tokyo Advanced Technology Center

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

60 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

Patients who can understand the contents of the research and obtain written informed consent
There are geriatric hearing loss (there are high-frequency hearing loss on both sides), and further classified into two groups with or without senile tinnitus.

Key exclusion criteria

If one of the following applies, it is excluded.
1 Patient without physical fitness to withstand the field test in the planned research period
2 Other patients who have severe complications, mental / psychological conditions, etc. and are considered inappropriate for participation in this study.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Sho Kanzaki

Organization

School of Medicine, Keio Univesity

Division name

Department of Otolaryngology

Zip code


Address

35 Shinjuku Shinanomachi Tokyo Japan

TEL

0353633827

Email

skan@keio.jp


Public contact

Name of contact person

1st name
Middle name
Last name Sho Kanzaki

Organization

School of Medicine, Keio Univesity

Division name

Department of Otolaryngology

Zip code


Address

35 Shinjuku Shinanomachi Tokyo Japan

TEL

0353633827

Homepage URL


Email

skan@keio.jp


Sponsor or person

Institute

Department of Otolaryngology, Keio Univesity

Institute

Department

Personal name



Funding Source

Organization

Tateishi Foundation

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor

Research Center for Advanced Science and Technology The University of Tokyo,
Tokyo Medical Center

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 01 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2017 Year 01 Month 06 Day

Date of IRB


Anticipated trial start date

2017 Year 02 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 01 Month 13 Day

Last modified on

2017 Year 01 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029523


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name